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ABSTRACT: Under denaturing conditions such as low pH and elevated
temperatures, proteins in vitro can misfold and aggregate to form long rigid rods
called amyloid ﬁbrils; further self-assembly can lead to larger structures termed
spherulites. Both of these aggregates resemble amyloid tangles and plaques associated
with Alzheimer’s disease in vivo. The ability to form such aggregates in a multitude of
diﬀerent proteins suggests that it is a generic ability in their mechanism to form.
Little is known about the structure of these large spherulites ranging from 5 to 100
microns and whether they can reproducibly form in amyloid β (1-40) (Aβ40), a 40-
amino acid residue peptide, which is one of the major components of Alzheimer’s
amyloid deposits. Here, we show that spherulites can readily form in Aβ40 under
certain monomerization and denaturing conditions. Using polarized and non-
polarized Raman spectroscopy, we analyzed the secondary structure of spherulites
formed from three diﬀerent proteins: insulin, β-lactoglobulin (BLG), and Aβ40.
Visually, these spherulites have a characteristic “Maltese Cross” structure under
crossed polarizers through an optical microscope. However, our results indicate that insulin and Aβ40 spherulites have similar
core structures consisting mostly of random coils with radiating ﬁbrils, whereas BLG mostly contains β-sheets and ﬁbrils that are
likely to be spiraling from the core to the edge.
1. INTRODUCTION
A number of degenerative diseases such as Alzheimer’s disease
(AD), type II diabetes, and Parkinson’s disease are associated
with aggregates of excess protein deposited in the tissue or
organs, making protein aggregation an active and very
important ﬁeld of research. These aggregates contain β-strands
that lie perpendicular to the ﬁbril axis; they are usually long (∼1
μm) and with an unbranched morphology, with ﬁbril diameters
ranging from 10 to 20 nm.1 Amyloid ﬁbrils are thought to form
via a polymerization mechanism, in which the protein ﬁrst
(partially) misfolds and forms stable nuclei, followed by the
attachment of monomers to the growing ends.2
However, larger-scale structures are seen in the post-mortem
brains of Alzheimer’s patients.3−5 Sections of brain tissue
viewed under crossed polarizers show that a structure is present
resembling the “spherulites” seen in many other in vitro
systems including insulin,6 β-lactoglobulin (BLG),7 hen egg
white lysozyme,8 human proislet amyloid polypeptide
(ProIAPP1‑48),
9 and amyloid β(1-42) (Aβ42).5 These proteins
have all been shown to demonstrate that the amyloid ﬁbrils
further self-assemble to form highly ordered spherical
aggregates, microns or tens of microns in size, which have
been named spherulites after similar structures that commonly
form from viscous or impure polymer melts.10
Spherulitic structures have been observed in a wide range of
alloys,11 volcanic rocks,12 synthetic polymers,13 liquid crys-
tals,8,14 and gels,15 with the literature on these structures dating
back as far as the 19th century. Starch granules have also been
described as spherulites, along with certain carbohydrates such
as chitin, which forms such structures through lateral molecular
association.16 Between crossed polarizers, spherulites exhibit
characteristic “Maltese cross” patterns, which rotate as the
polarizers are rotated.6
The characteristic Maltese cross pattern has been observed in
a rat model of AD,17 in brains of human patients suﬀering from
Creutzfeldt−Jakob disease,18 and in neuritic plaques, a hallmark
of AD,3,4 as well as in other protein systems in vivo,19,20
suggesting that the mechanism to form both spherulites in vitro
and plaques found in many amyloid diseases may be similar.21
House et al. were the ﬁrst to observe spherulites formed from
in vitro Aβ42 and compare them to spherulites in the human
brain tissue.5 During this study, House et al. showed that
copper abolished the secondary structure β-sheet of preformed
Aβ42 amyloid ﬁbrils, whereby copper binds to ﬁbrillar Aβ42.
These ﬁndings are signiﬁcant to the ﬁeld and could potentially
be beneﬁcial for AD therapy.5 In collaboration with House et
al., we have formed in vitro spherulitic aggregates in Aβ42 and
conﬁrmed the characteristic Maltese cross pattern.4 In this
study, the Aβ42 spherulites were formed under near
physiological conditions, after preformed aggregates were ﬁrst
abolished following an addition of an excess of copper in Aβ42.
Interestingly, the in vitro Aβ42 spherulites were near-identical
structures to that observed in 30 μm-thick sections of diseased
brain tissue from patients with AD.4,21 More recently, Exley et
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al. also have shown that ProIAPP1‑48 could form spherulites and
that copper was a potent in vitro inhibitor.9,22 This has major
implications for type 2 diabetes because IAPP and ProIAPP1‑48
are associated with the death of β cells in the pancreas.22 Large
spherically symmetric structures have been reported to form in
amyloid β(1-40) (Aβ40),23,24 but their structures have not been
shown to exhibit the Maltese cross patterns found in vivo.3
One challenge, readily discernible in the literature, is the
irreproducibility of the starting material when working with
Aβ.25 Studying Aβ in vitro requires a well-deﬁned material, but
the intrinsic propensity of Aβ to self-associate creates
substantial experimental problems when attempting to
reproducibly form aggregates.26 This issue with Aβ studies
has led to the adoption of peptide preparation procedures that
vary from group to group. The overall aim in each case is to
remove all preformed aggregates to give a reproducible
homogeneous initial state of the peptide that will give reliable
and robust kinetics, but the variability in subsequent outcomes
suggests that this may not have been achieved. The preparation
method for forming spherulites in Aβ42 has been well
documented by Exley et al.4 Here, we focus on the in vitro
preparation method for forming spherulites in Aβ40.
The observed Maltese cross pattern was mathematically
shown by Morse et al. to be caused by the uniaxial behavior of
the building blocks (amyloid ﬁbrils in the case of protein
aggregates) that are oriented radially within the spherulites.27
Light paths passing through a spherulite encounter many ﬁbrils
orientated at diﬀerent angles. The overall retardation along the
light path is the sum of the individual retardations from every
contributing ﬁbril. At the center of the spherulite, the total
retardation is zero due to the cancellation of eﬀects in diﬀerent
directions; it reaches a maximum at approximately two-thirds
from the center of the spherulite and then decreases to zero at
the periphery, as the decrease in the thickness counteracts the
birefringence of the ﬁbers.27−30
The dark centers of the spherulites formed from diﬀerent
proteins have various core sizes that do not correlate with the
diameter of the aggregates.6,31 These non-birefringent cores still
form in insulin even when ﬁltration is used before denaturing,
suggesting that the core is due to some structure of the protein
and not from any external eﬀect. The non-birefringent core in
insulin is thought to be due to collapsed ﬁbrils that have lost
their orientation because of stress as the spherulite continues to
grow;7 however, this hypothesis has not been proven. We have
previously shown that although the optical birefringence
patterns of insulin and β-lactoglobulin spherulites are diﬀerent,
the cores of the spherulites are too small to directly compare
the birefringence signals.32
Many techniques, including nuclear magnetic resonance
(NMR), Fourier transform infrared (FTIR), and Raman
spectroscopy, have been used to compare the secondary
structure of native proteins with that of denatured proteins that
form amyloid ﬁbrils.33−44 In particular, both native insulin and
BLG show a remarkable spectral change in the amide I region
because of carbonyl stretching (CO) after forming amyloid
Figure 1. (A) Image of a typical insulin spherulite from the optical microscope attached to the Raman spectroscope. The blue and black arrows
indicate the x- and y-directions, respectively. The scale bar is 10 μm. (B) Amide spectra region from the location indicated by the green dot in (A).
Exposure time of 100 s. Assigned peaks, individual ﬁts, and an overall ﬁt are shown in the ﬁgure. (C) Raman peak intensities for the β-sheet, α-helix,
and random coil across the insulin spherulite in the x-direction (top) and y-direction (bottom), where 0 μm marks the center. The β-sheet intensity
drops signiﬁcantly at the center of the spherulite, whereas the random coil intensity increases slightly. (D) Percentage contributions of the β-sheet, α-
helix, and random coil in the x- and y-directions. The largest contribution is from the β-sheet, which decreases at the center. (E) Raman peak
intensities for the β-sheet, α-helix, and random coil in the insulin spherulite as the material below the focus point increases (increasing z depth),
where 0 μm is the coverslip plane. (F) Polarized β-sheet intensity across the spherulite in the x and y paths as indicated in Figure S1F. The β-sheet
intensity is a minimum at the medians of the x-paths, suggesting that the ﬁbrils are perpendicular to the direction of polarization at this point.
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ﬁbrils.34,41,45,46 The peaks of interest are those assigned to the
β-sheet, α-helix, and random coil structures.
Spatially localized Raman measurements allow for a
secondary structure or crystallinity to be investigated at
diﬀerent points within a given aggregate. Galiotis et al.
successfully used this technique to evaluate the crystallinity in
isotactic polypropylene (iPP) along the diameter of a spherical
aggregate.47 By analyzing the intensity signal of the 809 cm−1
band (corresponding to crystallinity) normalized by the 830,
841, and 854 cm−1 bands (corresponding to noncrystallinity)
along the diameter, they showed that crystallinity was
symmetric and peaked at the nucleus. Using a setup similar
to that used by Galiotis et al., we use Raman spectroscopy to
analyze the secondary structure of the amyloid ﬁbrils that are
thought to be radially orientated within a spherulite. The utility
of Raman spectroscopy as a beneﬁcial technique to analyze
anisotropic biological specimens was also recently reported by
Lednev et al. who showed that the structural organization of
insulin ﬁbrils could be revealed using this methodology.46
Previous preliminary work on insulin alone showed a
dramatic increase in the random coils and a decrease in the
β-sheet content in the central region.32 Here, we show the
secondary structure as a function of position across the
diameter of the spherulites in insulin, BLG, and Aβ40, and how
these structures diﬀer from one another. The orientations of
the ﬁbrils within a spherulite are also compared using polarized
Raman spectroscopy.
2. RESULTS AND DISCUSSION
2.1. Secondary Structure of Insulin Spherulites. An
insulin spherulite (formed under acidic conditions and elevated
temperatures, see Experimental Section) visualized using the
microscope attached to a Raman spectrometer is shown in
Figure 1A, where the dotted line highlights the boundary of the
spherulite. To compare the secondary structures across the
spherulite, spectra were recorded, analyzed, and ﬁtted every 5
μm along the x- and y-axes as indicated by the blue and black
arrows, respectively. A typical Raman spectrum was recorded
from the insulin spherulite (indicated by the green dot in
Figure 1A), and ﬁtted peaks are shown in Figure 1B, where the
main peaks of interest are in the amide I region (1600−1700
cm−1).
A dominant peak is clearly seen at approximately 1673 cm−1,
corresponding to the β-sheet structure.48 Because native insulin
is mainly α-helical (peak at 1649 cm−1) and does not contain
any structures incorporating such a large quantity of β-sheets,49
the spherulite must contain a substantial quantity of denatured
proteins in the form of amyloid ﬁbrils. Raman peaks assigned to
the β-sheet, α-helix, and random coils in the amide I region are
given in Table 1.
The absolute intensity (which is aﬀected by the density and
the thickness of the material) of the peaks can be plotted at
each location across the spherulite in both the x- and y-
directions, as shown in Figure 1C. Although there is a drop in
intensity for both β-sheet and α-helix at the center, the signal
does not drop to zero, suggesting that amyloid is present in the
section through the core region. However, the random coil
intensity is a maximum at the core, suggesting that more
amorphous material is located at the center of the spherulite
where the birefringence is lower, along with a small proportion
of amyloid.
On analyzing the absolute signal across the spherulites, we
can gain further structural information following a normal-
ization procedure. Figure S1A shows a schematic representation
of the laser penetration through the spherulite. The absolute
intensity of the secondary structures is higher in the thickest
region of the spherulite (region two in Figure S1A). To account
for this thickness change across the spherulite whereby the
edges have a lower mass thickness, it is necessary to normalize
with respect to the sum of all three secondary structures so that
the diﬀerence in sample illumination will be negligible. For the
β-sheet intensity, the normalized intensity will be
⟨ ⟩ =
+ +β
β
β α
I
I
I I I,norm R (1)
where Iβ is the intensity of the β-sheet structure, Iα is the
intensity of the α helix structure, and IR is the intensity of the
random coil structure. At positions 1 and 2 in Figure S1A, the
normalized intensities are
λ
λ λ λ
⟨ ⟩ =
+ +β
β
β α
I
I
I I I,norm 1 R (2)
and
γ
γ γ γ
⟨ ⟩ =
+ +β
β
β α
I
I
I I I,norm 2 R (3)
where λ and γ are factors that take into account the volume
fraction of the material, where γ > λ. Both factors cancel out,
and therefore the volume of penetration is not an issue when
analyzing the normalized contribution of the secondary
structures at positions along the spherulite.
Figure 1D shows the normalized intensities representing the
percentage of each type of secondary structure in the x- and y-
directions, where 100% is the total contribution of the three
combined secondary structures. The largest contribution at any
location in the spherulite is from the β-sheets, which makes up
approximately 75% of the structure near the spherulite edge,
dropping to approximately 60% at the core. The random coil
contribution is a maximum at this central point, increasing from
approximately 15% to 25% near the edge, indicating the
presence of an amorphous material at the core. The same trend
was found in the y-direction. The increase in the amorphous
material at the core would explain the dark center in the
Maltese cross patterns readily observed in the spherulites,
because one would expect its birefringence to be low.
The secondary structure distribution as a function of position
was similar in two more insulin spherulites (see Figure S1B,C).
The same trend in all spherulites suggests that the non-
birefringent core contains a larger amount of random coils and
less β-sheets, and hence there is no uniform structure across the
whole spherulite. Thus, the non-birefringent core is likely to be
made up of a disordered material and a small quantity of
amyloid ﬁbrils. A higher proportion of random coils at the core
suggests that the spherulite formation may begin with the
Table 1. Raman Band Assignments48
wavenumber/cm−1 structure assignment
1673 β-sheet
1649 α-helix
1614 random coils
1603 phenylalanine
1585 aromatics
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amorphous protein acting as a nucleus with the ﬁbrils then
growing out from this center50 or the collapse and
disorganization of the ﬁbrils at the center.
The intensities of the β-sheet, α-helix, and random coil
signals were compared with increasing z-depth within a
spherulite at three independent locations, two avoiding the
center (black arrows) and one through the center (red arrow),
as shown in the schematic spherulite in Figure S1D.
Figure 1E (top and bottom panels) shows that the intensity
increases for all assigned secondary structures as the thickness
and therefore the scattering volume increases at the left hand
and right hand sides of the spherulite (black arrows on Figure
S1D). The intensities were not normalized because the volume
illumination is crucial for the depth analysis. The volume of
material for which light is scattered will increase by 20 μm3 as
the depth is increased by 5 μm at each position and the beam
spot size is approximately 4 μm2 in cross section regardless of
depth. A diﬀerent trend is observed in Figure 1E (middle
panel) when increasing the depth through the core (red arrow
on Figure S1D) compared with the case when the core is
avoided. The gradient of intensity of the β-sheet (and the α-
helix) decreases when the laser penetrates through the
approximate location of the core and then increases as it
leaves the core. This diﬀerence in trend at the core, compared
with the edge of the spherulite, can be explained by the
decrease in the β-sheets and increase in the random coils within
the core. The β-sheet signal does not increase when going
through the core (z-depth ≈ 5−10 μm), consistent with the
drop in the β-sheet intensity observed in the x- and y-
directions. This analysis is consistent with a spherical core of
amorphous/random coil material surrounded above and below
by the radiating β-sheet-rich ﬁbrils.
2.2. Amyloid Fibril Orientations in Insulin Spherulites.
The Maltese cross extinction pattern suggests that the
spherulite is composed of radially orientated amyloid ﬁbrils.6
To conﬁrm this using polarized Raman spectroscopy, the
intensity signal of the β-sheet content can be compared across
the spherulite, indicating the orientation of the ﬁbrils. This
relationship is given by the formula
θ=I a cos4 (4)
where a is a constant and θ is the angle between the molecular
bonding of the protein backbone and the direction of the
polarized laser (and therefore analyzer because both are parallel
to each other).51 A maximum intensity will arise when the C
O carbonyl groups and hence the ﬁbrils are parallel to the
direction of polarization (Figure S1E).52
Figure S1F shows an insulin spherulite visualized using
confocal microscopy in 2D; the direction of the laser
polarization is given by the black double-headed arrow, which
is parallel to the deﬁned x-axis of the spherulite. The intensity
across the spherulite is recorded along six paths; three in the x-
direction, X1, X2, and X3, and three in the y-direction, Y1, Y2, and
Y3, where X2, and Y2 go through the core as shown in Figure
S1F.
The intensities were normalized with respect to the random
coil intensity only at the corresponding positions because the α-
helix signals are very weak when using polarized laser Raman
spectroscopy. Opposing trends are apparent when comparing
the β-sheet intensity in the x- and y-directions. The minimum
and maximum β-sheet intensities occur at the middle of all x
and y paths, respectively. In the x-direction (paths that are
parallel to the direction of polarization), the overall signal is
higher than in the y-direction. This suggests that the CO
groups within the ﬁbrils are mostly aligned with the x-direction.
The β-sheet intensity increases at either side of the minima in
the x-direction, suggesting that the ﬁbrils are more aligned with
the direction of polarization away from the median of the X
paths. At the core, more ﬁbrils may be disordered and from
nonpolarized Raman, we can see that there is also more
amorphous material giving the lowest intensity signal.
In the y-direction, the scattering from the spherulite increases
at the center, whereas the nonpolarized data across the
diameter decreases at the center. Because the form of the
polarized and nonpolarized signals is not the same across the
identical path (Y2 path), the polarized data must be a result of
the orientation of ﬁbrils from both the x- and y-directions
combined. The β-sheet intensity is a maximum at the middle of
the three paths along the Y-direction, implying that the ﬁbrils
are most aligned with the direction of polarization at this point.
The β-sheet intensity is a minimum at the edges. The results
from the polarizing data suggest that the ﬁbrils radiate out from
the center of the spherulite (see Figure S2A for schematic
interpretations), consistent with the earlier observations.50
2.3. Secondary Structure and Fibril Orientations in
BLG. Like insulin, BLG also forms spherulites readily under
acidic conditions and elevated temperatures in vitro. However,
unlike insulin spherulites, Figure 2A shows that the absolute
intensity of all secondary structures is maximum at the core of
the BLG spherulite. This suggests that BLG spherulites may
Figure 2. (A) Raman peak intensities for the β-sheet, α-helix, and random coil across a BLG spherulite in the x-direction (top) and y-direction
(bottom), where 0 μm marks the center. (B) Percentage of the β-sheet, α-helix, and random coil across a BLG spherulite in the x-direction (top) and
y-direction (bottom), where 0 μm marks the center. (C) Polarized β-sheet intensity across a BLG spherulite to indicate the orientation of the ﬁbrils
in the x- and y-axes.
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have more β-sheet material in general at their centers in
contrast to insulin spherulites that have greater core diameters.
Both insulin and BLG spherulites consist of approximately
75% of β-sheet overall. However, the BLG levels of all three
secondary structures seem to be constant across the spherulite
(Figure 2B; results reproduced in two more BLG spherulites,
Figure S2B,C) in contrast to insulin, which decreases in the β-
sheet and increases in the random coil content toward the
center.
Polarized Raman spectroscopy showed that the insulin
spherulites possessed radial symmetry, as discussed in the
previous section (Figure 1F). BLG diﬀers in its internal
structure (Figure 2C) because it has ﬁbrils aligned more at one
side of the spherulite in both the x and y-directions. It has been
well documented in the lab of Mezzenga et al. that at the single
ﬁbril level, the structure and stiﬀness of the BLG ﬁbrils can be
altered depending on the environmental denaturing conditions
(incubation temperature, pH, ionic strength, and surface
interface).53−57 For example, BLG ﬁbrils can form a twisted
ribbon or helical ribbon structure when grown under mild or
severe denaturing conditions, respectively.54,55 Our observa-
tions suggest that the ﬁbril may spiral out from the core (not
necessarily twisting along the ﬁbril axis), as shown schematically
in Figure S2D; this structure would then give β-sheet a
maximum when the ﬁbrils at the end of the spherulite were
curved so that the ﬁbrils were parallel with the orientation of
polarization. The structure of the bending ﬁbrils and no core is
consistent with the results of the work by Poulin et al.: when
ﬁbrils radiate out from a seed, the splay energy is lower than the
bending energy giving radial spherulites, whereas bending ﬁbrils
arise when there is no core and the bending energy is lower.58
The implied BLG structure is also similar to the bending
extinction pattern observed from the phase transitions of radial
hedgehogs to hyperbolic structures in nematic liquid crystals
because of the reorientation of molecules.15
BLG spherulites shown here diﬀer from insulin in terms of
the structure of the core and orientation of the ﬁbrils. These
diﬀerences in the structure may reﬂect diﬀerences in the
properties of the ﬁbrils themselves or the way that they
aggregate and pack. Although these structures appear similar
Table 2. Monomerize and Disaggregate Aβ Before Spherulite Formation25,60
method 1 method 2 process
dissolve 1 mg of peptide in 1 mL of TFA (takes approximately 10 min),
sonicate for 30 s on ice, freeze peptide with liquid nitrogen
N/A solubilizes Aβ eﬀectively and
disaggregates any pre-existing
aggregates
lyophilize overnight N/A removes TFA
dissolve in 1 mL of HFIP and leave on ice for 5−10 min dissolve in 1 mL of HFIP and leave on ice
for 5−10 min
further disrupts any aggregates
divide into aliquots and dry using a rotatory evaporator at room
temperature.
divide into aliquots and dry using a rotatory
evaporator at room temperature.
removes HFIP
Figure 3. (A) Optical image of Aβ40 spherulites formed using hexaﬂuoroisopropanol (HFIP) followed by 14 days of incubation at 37 °C with 0.1 M
NaCl at a peptide concentration of 300 μM. (B) Environmental scanning electron microscopy (ESEM) images of a spherulite formed in the Aβ40
peptide at 300 μM, incubated for 14 days at 37 °C. The scale bar is 20 μm (C) Insulin spherulite formed at 1 mM, incubated for 24 h at pH 2. The
scale bar is 20 μm (D) Raman peak intensities for the β-sheet, α-helix, and random coil across an Aβ40 spherulite in the x-direction (top) and y-
direction (bottom), where 0 μm marks the center. (E) Percentage of the β-sheet, α-helix, and random coil across an Aβ40 spherulite in the x-
direction (top) and y-direction (bottom), where 0 μm marks the center. (F) Polarized β-sheet intensity across an amyloid β (Aβ) spherulite to
indicate the orientation of the ﬁbrils in the x and y paths.
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through an optical microscope, detailed secondary structures
show diﬀerences that cannot be detected by visual methods
alone.
2.4. Secondary Structure and Fibril Orientations in
Aβ40. The main issue when forming amyloid aggregates in
vitro from Aβ is their irreproducibility apparently due to rapid
self- and random aggregation.25 Here, we formed Aβ40
spherulites by employing a new reproducible monomerization
and denaturing protocol. First, we tested two preparation
methods aimed at eliminating pre-existing aggregates, creating a
monomeric Aβ stock solution from peptide lyophilizates. The
ﬁrst method involves the use of triﬂuoroacetic acid (TFA) and
HFIP separately to disrupt hydrophobic interactions in
aggregated amyloid preparations, as shown in Table 2. This
method has been previously shown to yield monomeric peptide
solutions with α-helical and random coil secondary structures.25
The second method uses HFIP alone, as shown in Table 2,
which avoids crossing the isoelectric point (pI) where the
peptides are most insoluble, a condition which could lead to
rapid aggregation and may prevent subsequent formation of
long-range ordered structures.59
Following both preparation methods, a 50 mM sodium
phosphate buﬀer (pH 7.4) was prepared with the addition of
0.1 M NaCl and was added to the powdered Aβ40 peptide in
1.5 mL Eppendorfs to give concentrations of 30, 50, 150, and
300 μM. The lowest peptide concentration has been widely
used for amyloid ﬁbril experiments, without spherulites being
identiﬁed; therefore, the higher concentrations (150 and 300
μM) may be necessary to form larger structures such as
spherulites. The peptide concentrations were veriﬁed within a
5% error using a Nanodrop ND1000 spectrophotometer (see
Experimental Section). The peptide solutions were incubated at
37 °C for 14 days, and samples produced using all incubation
conditions were repeated three times. Using both TFA and
HFIP separately before incubation resulted in all samples
forming amyloid ﬁbrils. However, only one repeat from two
diﬀerent conditions formed spherulites: 150 μM at 37 °C and
300 μM, at 37 °C. However, using HFIP alone to monomerize
the protein resulted in all repeat samples incubated at 37 °C
with 0.1 M NaCl at peptide concentrations of either 150 or 300
μM forming spherulites. It therefore seems that indeed avoiding
the pI of the protein is vitally important for reproducible
spherulite formation.
The characteristic Maltese cross pattern of Aβ40 spherulites
(Figure 3A) resembled those readily observed in insulin and
BLG;6,31 both have four quadrants of birefringence and a non-
birefringent core. This second protocol prevents the peptide
from crossing its pI (where the peptide is least soluble), and
hence random aggregation may be slower, giving spherulites the
time to form. This result indicates the importance of the
preparation method and the environmental conditions when
forming spherulitic amyloid aggregates. To gain further
structural information, ESEM was used to image the spherulites
formed in Aβ40 at a concentration of 300 μM, as shown in
Figure 3B. For comparison, the spherulites formed in insulin
are shown in Figure 3C. It is quite clear from the images that
spherulites from both insulin and Aβ40 have similar
morphologies from an external perspective.
As with that of the insulin spherulites, Raman spectroscopy
of the Aβ40 spherulite reveals a decrease in the absolute β-sheet
intensity at the core (Figure 3D) and a slight increase in the
random coil structure with the spherulite containing approx-
imately 80% of a β-sheet structure, which drops to 70% at the
core (Figure 3E). The random coil structure increases from
approximately 5 to 10%. However, in contrast to insulin, the
results suggest that there is more β-sheet content in an Aβ
spherulite than in an insulin spherulite; the β-sheet percentage
also decreases less across the Aβ spherulite, a result reproduced
in two other spherulites (Figure S2E,F).
The polarized Raman secondary structure signals (Figure 3F)
show the same trend as insulin spherulites. Hence, the
proposed structure for Aβ40 spherulites is the same. Aβ40
spherulites are structurally more similar to those of insulin than
BLG, having a core region with more random coils and less β-
sheets, and radially orientated ﬁbrils outside the core.
3. EXPERIMENTAL SECTION
3.1. Sample Preparation. BLG (product no. L0130) and
bovine insulin (product no. I5500) were obtained from Sigma-
Aldrich. These and all other chemicals were of analytical grade
or better and used without further puriﬁcation. Solutions were
prepared by dissolving the required amount of protein powder
in distilled and deionized water to give concentrations of 5.6
and 40 mg/mL for insulin and BLG, respectively. The pH was
adjusted with HCl for insulin (pH 2) and BLG (pH 1.6). The
samples were incubated for 24 h at 70 °C to form spherulites.
Aβ was purchased from Bachem (Bubendorf, Switzerland) as
lyophilized triﬂuoroacetate salts (Batch H1194). Two methods
were used to form spherulites, the ﬁrst method eliminated pre-
existing aggregates using TFA, followed by HFIP to disrupt
hydrophobic interactions. The second method used HFIP
alone, creating a monomeric Aβ stock solution, after which a 50
mM sodium phosphate buﬀer (pH 7.4) with the addition of 0.1
M NaCl was prepared and added to the Aβ40 powder peptide
in 1.5 mL Eppendorfs to give ﬁnal concentrations of 30, 50,
150, and 300 μM. All aliquot concentrations were conﬁrmed by
analyzing 1 μL of aliquots using a Nanodrop ND1000
spectrophotometer that is speciﬁcally designed for accurately
measuring the concentrations of very small volumes. The Aβ40
peptide samples were then incubated at 37 °C for 14 days.
3.2. Raman Spectroscopy. A Renishaw System 2000
Raman spectrometer coupled to an Olympus microscope was
used to monitor the secondary structure within the spherulites.
A HeNe laser (λ = 633 nm), focused to a spot size of
approximately 2 μm on the surface of the sample using a 50×
objective lens, was used to excite Raman scattering from the
spherulites. To obtain a clear Raman spectra, an exposure time
of 100 s (ﬁve accumulations of 20 s) was used. This procedure
was repeated three times at each location to give an average
spectrum and the corresponding standard error of the mean
(SEM). In sections where the orientation of ﬁbrils was
examined, the monochromatic light from the laser was
polarized using a polarizing ﬁlter, and the analyzer was in
place to detect only the polarized light from the scattered
radiation.
3.3. Analysis of Data. Raman spectra were collected in the
range of 1550−1750 cm−1, three times at each location. These
spectra were ﬁtted using mixed Gaussian and Lorentzian
functions (see Figure 1B for an example of ﬁtting) using the
Wire 3.1 software (Renishaw, UK). For the secondary structure
analysis, the absolute intensities were normalized by the sum of
all secondary structures to account for the variation in density
and to give a percentage contribution of each secondary
structure, where 100% is the total contribution of all three
secondary structures (see eqs 1 and 2 for the normalization
procedure). Only in the case of analyzing the orientation of
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ﬁbrils, using polarized Raman, were the β-sheet intensities
normalized with the random coil peaks because the α-helix
signal was weak. Spherulites were analyzed individually because
they vary in size as do their cores.
3.4. ESEM. All spherulite imaging was carried out on an
Electroscan ESEM 2010 microscope (FEI UK). Aliquots of the
Aβ40, BLG, and insulin solutions were pipetted onto copper
stubs, which were then placed inside of the chamber of the
microscope. Using a Peltier-chip-controlled device located
under the sample holder, samples were allowed to equilibrate to
2 °C and were kept suﬃciently cold so that that liquid did not
fully evaporate when the chamber pressure was pumped down.
Drops of water were placed around the sample to maintain
hydration while pumping down. The chamber was ﬂooded with
water vapor repeatedly until a pressure of less than 5 Torr was
achieved.5
4. CONCLUSIONS
Insulin and Aβ40 spherulites are dominated at their edges by β-
sheet structures, whose contribution decreases at the center but
is not negligible. The random coil intensity increases at the
center, suggesting that a combination of amorphous material
and unaligned amyloid ﬁbrils make up the core. The ﬁbrils were
shown to radiate out from the center in insulin and Aβ proteins.
The increased disordered material and reduced amyloid ﬁbril
content at the core may explain the absence of birefringence in
this region using cross-polarized light.
The insulin and Aβ40 spherulite formation may require
amorphous protein to act as a nucleus from which subsequent
ﬁbril growth can occur. These ﬁbrils at the center may collapse
as the spherulite continues to grow, which accounts for the β-
sheet presence at the core albeit reduced in amount. The
collapsing ﬁbrils lose their orientation showing no birefringence
between crossed polarizers. The orientation of the ﬁbrils was
shown to be radial from the center because of the increasing
and decreasing β-sheet intensities in diﬀerent orientations
depending on the alignment with the direction of polarization.
BLG showed a dramatic increase in the β-sheet intensity at
the center, which may be due to this region of the spherulite
being denser as when normalized, the β-sheet percentage
remained almost constant. The amyloid ﬁbrils in BLG did not
have the same orientation as in insulin or Aβ40. Instead of
radial symmetry, the observed β-sheet intensities imply a spiral
of ﬁbrils from the core to the edge.
Forming spherulites in Aβ40 is possible and reproducible
under various conditions including those simulating physio-
logical conditions in vitro. However, to accomplish this, we
found that using HFIP alone before incubation is necessary for
the formation of spherulites consistently in Aβ40, when
incubated at high concentrations (150 or 300 μM) for 14
days at 37 °C. Passing through the pI seems to hinder
reproducibility.
Although the proteins reported to form spherulites look
macroscopically similar under polarized light, their internal
structures may diﬀer, and hence, their formation and packing
cannot be assumed to be the same.
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(28) Grańaśy, L.; Pusztai, T.; Tegze, G.; Warren, J. A.; Douglas, J. F.
Phys. Rev. E: Stat., Nonlinear, Soft Matter Phys. 2005, 72, 011605.
(29) Smith, M. I.; Fodera,̀ V.; Sharp, J. S.; Roberts, C. J.; Donald, A.
M. Colloids Surf., B 2012, 89, 216−222.
(30) Domike, K. R.; Hardin, E.; Armstead, D. N.; Donald, A. M. Eur.
Phys. J. E: Soft Matter Biol. Phys. 2009, 29, 173−182.
(31) Domike, K. R.; Donald, A. M. Int. J. Biol. Macromol. 2009, 44,
301−310.
(32) Krebs, M. R. H.; Domike, K. R.; Cannon, D.; Donald, A. M.
Faraday Discuss. 2008, 139, 265−274.
(33) Hou, L.; Shao, H.; Zhang, Y.; Li, H.; Menon, N. K.; Neuhaus, E.
B.; Brewer, J. M.; Byeon, I.-J. L.; Ray, D. G.; Vitek, M. P.; Iwashita, T.;
Makula, R. A.; Przybyla, A. B.; Zagorski, M. G. J. Am. Chem. Soc. 2004,
126, 1992−2005.
(34) Ortiz, C.; Zhang, D.; Ribbe, A. E.; Xie, Y.; Ben-Amotz, D.
Biophys. Chem. 2007, 128, 150−155.
(35) Zagorski, M. G.; Barrow, C. J. Biochemistry 1992, 31, 5621−
5631.
(36) Zandomeneghi, G.; Krebs, M. R. H.; McCammon, M. G.;
Fan̈drich, M. Protein Sci. 2004, 13, 3314−3321.
(37) Lin, S.-Y.; Chu, H.-L. Int. J. Biol. Macromol. 2003, 32, 173−177.
(38) Maiti, N. C.; Apetri, M. M.; Zagorski, M. G.; Carey, P. R.;
Anderson, V. E. J. Am. Chem. Soc. 2004, 126, 2399−2408.
(39) Eker, F.; Griebenow, K.; Schweitzer-Stenner, R. Biochemistry
2004, 43, 6893−6898.
(40) Chen, P.; Shen, A.; Zhao, W.; Baek, S.-J.; Yuan, H.; Hu, J. Appl.
Opt. 2009, 48, 4743−4748.
(41) Ikeda, S.; Li-Chan, E. C. Y. Food Hydrocolloids 2004, 18, 489−
498.
(42) Nonaka, M.; Li-Chan, E.; Naiki, S. J. Agric. Food Chem. 1993, 41,
1178−1181.
(43) Buchanan, L. E.; Carr, J. K.; Fluitt, A. M.; Hoganson, A. J.;
Moran, S. D.; de Pablo, J. J.; Skinner, J. L.; Zanni, M. T. Proc. Natl.
Acad. Sci. U.S.A. 2014, 16, 5796−5801.
(44) Stroud, J. C.; Liu, C.; Teng, P. K.; Eisenberg, D. Proc. Natl. Acad.
Sci. U.S.A. 2012, 20, 7717−7722.
(45) Lippert, J. L.; Tyminski, D.; Desmeules, P. J. J. Am. Chem. Soc.
1976, 98, 7075−7080.
(46) Sereda, V.; Sawaya, M. R.; Lednev, I. K. J. Am. Chem. Soc. 2015,
137, 11312−11320.
(47) Gatos, K. G.; Minogianni, C.; Galiotis, C. Macromolecules 2007,
40, 786−789.
(48) Dong, J.; Wan, Z.; Popov, M.; Carey, P. R.; Weiss, M. A. J. Mol.
Biol. 2003, 330, 431−442.
(49) Blundell, T. L.; Cutfield, J. F.; Cutfield, S. M.; Dodson, E. J.;
Dodson, G. G.; Hodgkin, D. C.; Mercola, D. A.; Vijayan, M. Nature
1971, 231, 506−511.
(50) Rogers, S. S.; Krebs, M. R. H.; Bromley, E. H. C.; van der
Linden, E.; Donald, A. M. Biophys. J. 2006, 90, 1043−1054.
(51) Gommans, H. H.; Alldredge, J. W.; Tashiro, H.; Park, J.;
Magnuson, J.; Rinzler, A. G. J. Appl. Phys. 2000, 88, 2509.
(52) Lefev̀re, T.; Rousseau, M.-E.; Peźolet, M. Appl. Spectrosc. 2006,
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